Most of the patients with HIV who received infusions of modified versions of their immune cells remain healthy as many as 11 years after treatment, according to a study published in the journal Science Translational Medicine. Samples taken from patients showed the modified cells were at stable levels, researchers said. The findings indicate that modified cells are safe and continue to work more than a decade after infusion, which could open the treatments to less serious conditions.
Modified cells prove safe in long-term HIV study
SmartBrief Job Listings for Health Care